[HTML][HTML] HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response

M Hashemi, M Rashidi, K Hushmandi… - Pharmacological …, 2023 - Elsevier
High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the
nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this …

Notch signaling pathway: a new target for neuropathic pain therapy

Y Zhang, T Wang, S Wu, L Tang, J Wang… - The Journal of …, 2023 - Springer
The Notch gene, a highly evolutionarily conserved gene, was discovered approximately 110
years ago and has been found to play a crucial role in the development of multicellular …

Therapeutic potential of TRPM8 channels in cancer treatment

SV Ochoa, Z Casas, SL Albarracín… - Frontiers in …, 2023 - frontiersin.org
Cancer is a multifactorial process associated with changes in signaling pathways leading to
cell cycle variations and gene expression. The transient receptor potential melastatin 8 …

Role of the lncRNA/Wnt signaling pathway in digestive system cancer: a literature review

P Li, X Ma, D Huang - European Journal of Medical Research, 2024 - Springer
The long noncoding RNA (lncRNA)/Wingless (Wnt) axis is often dysregulated in digestive
system tumors impacting critical cellular processes. Abnormal expression of specific Wnt …

Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression

R Strippoli, R Niayesh-Mehr, M Adelipour, A Khosravi… - Cancers, 2024 - mdpi.com
Simple Summary This manuscript focuses on the complex relationships between autophagy
and epithelial mesenchymal transition (EMT) in cancer. Autophagy, a cellular degradation …

[HTML][HTML] Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and …

M Hashemi, P Daneii, MA Zandieh, R Raesi… - Non-coding RNA …, 2024 - Elsevier
The emergence of RNA modifications has recently been considered as critical post-
transcriptional regulations which governed gene expression. N 6-methyladenosine (m 6 A) …

Targeting notch-related lncRNAs in cancer: Insights into molecular regulation and therapeutic potential

R Siddique, G Kumar, MGM Johar, A Kumar… - … -Research and Practice, 2024 - Elsevier
Cancer is a group of diseases marked by unchecked cell proliferation and the ability for the
disease to metastasize to different body areas. Enhancements in treatment and early …

Notch signaling pathway in cancer: from mechanistic insights to targeted therapies

Q Shi, C Xue, Y Zeng, X Yuan, Q Chu, S Jiang… - … and Targeted Therapy, 2024 - nature.com
Notch signaling, renowned for its role in regulating cell fate, organ development, and tissue
homeostasis across metazoans, is highly conserved throughout evolution. The Notch …

A review of nuclear Dbf2-related kinase 1 (NDR1) protein interaction as promising new target for cancer therapy

J Lu, Y Feng, D Yu, H Li, W Li, H Chen… - International Journal of …, 2024 - Elsevier
Abstract Nuclear Dbf2-related kinase 1 (NDR1) is a nuclear Dbf2-related (NDR) protein
kinase family member, which regulates cell functions and participates in cell proliferation …

Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy

X Li, Y Wu, X Zhang, J Liu, Y Zhang, L Yuan… - International Journal of …, 2023 - Elsevier
The combined diagnostic imaging, chemotherapy, and gene therapy based on DNA
nanocarriers can reduce the toxic side effects and overcome multidrug resistance (MDR). In …